A single 11.1 kBq dose of [225Ac]αMSH-PEG-Cy5-C′ dot effectually controls tumor growth and improves survival compared with a nontargeted [225Ac]NH2-PEG-Cy5-C′ dot control and vehicle-treated groups. This evidence concerns the gene STAMBP and neoplasm.